Delivery Order SPE2DB22D3011-SPE2DB22FP9PL
Award Date 9/26/22
Potential Completion Date 9/27/22
Potential Value $117K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a $107,662.62 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The award is for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products, with a completion date of November 29, 2022. The contract has no set-aside designation. AmerisourceBergen Drug Corp has held numerous prior contracts with DLA to provide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $142,619.35 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. As a prime contractor, Amerisourcebergen Drug Corp has provided a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,053.72 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. The contract has a completion date of December 28, 2023 and was awarded on December 27, 2023. No set-aside designation was used....
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,268.60 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract has a completion date of January 17, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical...
- This federal contract award SPE2DX15D7057|SPE2DX24FLCEY was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,053.72 firm fixed price delivery order is for the supply of 0.5 mL MENQUADFI VIAL, a pharmaceutical product. The award has an ultimate completion date of August 2, 2024 and does not utilize any set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,350.27 firm fixed price delivery order is for the provision of the pharmaceutical product "MENQUADFI VIAL 0.5ML". The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,628.85 firm fixed-price delivery order is for the procurement of MENQUADFI VIAL 0.5ML medical products. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $11,437.35 firm-fixed-price contract is for the supply of 4565452753 MENQUADFI VIAL 0.5ML pharmaceutical products. The award has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that supports various government agencies and healthcare programs through multiple indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.73 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of July 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,601.99 firm fixed price delivery order is for PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of February 1, 2024 and was awarded on January 10, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received...